show less
show more
@pegbyron
@ed-tobias Hey Ed – hope all’s well. Wondering if you have thoughts about the report described here recently from Neurology: Effects of High and Low Efficacy Therapy in Secondary Progressive Multiple Sclerosis…describing no longterm advantage with heavier meds in reducing MS disability progression. That seems like big bad news for a lot of […] View
Member's groups
There were no groups found.
